Anti-Human APP Abeta40 Recombinant Antibody

Name: Anti-Human APP Abeta40 Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1248

YR1248

科研级 Ponezumab ( 泊奈组单抗 ), Anti-APP Abeta40 Recombinant Antibody, Research Grade Ponezumab

DATASHEET MSDS

Product Description

Alias	科研级 Ponezumab ( 泊奈组单抗 ), Anti-APP Abeta40 Recombinant Antibody, Research Grade Ponezumab
Catalog Number	YR1248
Molecular Name	Ponezumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease. Ponezumab was developed by Pfizer Inc. In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released.
CAS Number	1178862-65-1
Application	ELISA, IP, FCM, FuncS, Neut
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	APP Abeta40[Homo sapiens]

Login